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Malignant  tumors  of  the  paranasal  sinuses 
constitute  3%  of  all  head  and  neck  cancers.1 
Among these, paranasal fibrosarcoma, which is a 
malignant tumor of the fibroblasts, is extremely 
rare and there is limited report in the literature. 
Paranasal  sinus  sarcomas  constitute  7%  of  all 
head  and  neck  sarcomas2  and  lower  than  1% 
of  cancers  in  this  region.3,4 On  the  other  hand, 
gemistocytic astrocytoma which originates from 
astrocytes is a histological variant of low-grade 
diffuse astrocytoma (WHO grade II), and has high 
frequency of rapid tumor recurrence and malignant 
progression.5,6  It  grows  slowly;  however  often 
behave aggressively because of the presence of 
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gemistocytic cells which are neoplastic in nature. 
The incidence rate adjusted to the World Standard 
Population,  per  million  populations  per  year,  is 
2.28.7 Considering the incidence of entire low-grade 
diffuse astrocytomas, it is also a rare condition. 
Local  recurrences  and  distant  metastases  may 
occur  in  both  fibrosarcoma  and  gemistocytic 
astrocytoma.  However,  there  is  no  report  in 
which  the  metastatic  spread  of  gemistocytic 
astrocytoma to fibrosarcoma or vice versa in the 
literature.  An  occurrence  of  multiple  primary 
cancers with either gemistocytic astrocytoma or 
fibrosarcoma is also extremely rare. We reported 
this case since, to our knowledge, the patient was 
unique  in  whom  maxillary  sinus  fibrosarcoma 
and gemistocytic astrocytoma of brain developed 
synchronously  as  separate  primary  tumors. 
Furthermore,  although  there  have  been  several 
previous  reports  on  sarcomas  of  the  head  and 
neck, only few of them report sarcoma of the oral 
and maxillofacial region.8-11 The limited number of 
patients reported in these papers demonstrates 
the rarity of sarcomas in the oral and maxillofacial 
region (14 patients over 15 years,8 25 patients over 
35 years,9 10 patient over 8 years,10 and 32 patients 
over 25 years11). As a consequence of their variety 
of the originating tissue and their rarity, there is 
need to discuss clinical and pathological features, 
to establish standard treatment regime, and to be 
able to estimate prognosis of sarcomas of the oral 
and  maxillofacial  region.  Finally,  the  diagnosis 
of  sinonasal  malignancies  is  difficult.  Since  the 
early diagnosis is one the most important factor 
for  favorable  treatment  outcome,  to  detect  the 
possible early signs and symptoms of paranasal 
sinus cancer is essential. Therefore, the aim of 
this case report was to discuss the clinical course 
of the disease, outcome of the dual therapy with 
surgery  and  radiotherapy,  unusual  development 
of leukocytoclastic vasculitis during radiotherapy, 
and survival in such unusual presentation. Such 
data deserves to be recorded for the management 
protocols of prospective cases.
CASE REPoRt
A  48-year-old  male  Turkish  farmer  was 
admitted to our clinic with complaints of slight pain, 
sense of swelling and discomfort in the left-check, 
pressure to left eye with two-month duration. Past 
medical history of the patient revealed an excision 
of a brain tumor and its radiotherapy a year ago. 
Histopathological report, sections (Figure 1a (100x 
Hematoxilen eosin (HE)); Figure 1b (200xHE)), and 
previous  computerized  tomography  (CT)  (Figure 
2a) obtained from Antalya Government Hospital, 
where the brain tumor operation was performed, 
revealed  that  the  tumor  was  a  gemistocytic 
astrocytoma  (Grade  II  -  poorly  differentiated 
mass). The histopathological sections (Figure 1a 
(100xHE); Figure 1b (200xHE)) were characterized 
with  a  predominance  of  gemistocytes,  which 
are  neoplastic  cells.  Voluminous,  eosinophilic 
cytoplasm,  eccentric  nuclei,  plump  cell  process 
and  marked  cytoplasmic  accumulation  of  glial 
fibrillary  acidic  protein  (gemistocytes)  were 
also  seen  in  the  histopathological  sections.  An 
enlargement  of  the  heterogeneous  tumor  in  6 
cm diameter in the left-temporoparietal lobe was 
shifting  the  midline  to  the  right  on  CT-images 
(Figure 2a). 
The family history of the patient revealed an 
unknown femoral bone malignancy in his father. 
Although  no  significant  extra-  and  intra-oral 
swellings  were  present,  clinical  examination 
showed  localized  decrease  in  left-maxillary 
vestibular  depth  from  the  canine  to  the  second 
premolar region, relatively (Figure 3). Slight pain 
was present on palpation. There was no regional 
lymphadenopathy or any evidence suggests ocular 
involvement. While radiological examination with 
orthopantomography  (OPG)  showed  resorption 
at the internal surface of the left maxillary sinus 
(Figure 4), maxillary occlusal radiograph revealed 
an  enlarged  left  maxillary  sinus  with  poorly 
defined margins (Figure 5). Left-maxillary sinus 
filled by a mass in 36 x 53 x 57 mm dimensions was 
also apparent in CT-images (Figure 2b). Invasion 
of the left-maxillary sinus mass into the adjacent 
tissues  were  remarkable  with  its  extension  to 
the  anterolateral-,  inferior-,  medial-wall  of  the 
maxillary sinus, orbital cavity and pterygopalatinal 
fossa (T4). CT-images showed that the multiple 
gemistocytic  astrocytomas  (Figure  2a)  were 
coexist with the left maxillary sinus mass (Figure 
2b) on the preoperative CT-images (with contrast) 
obtained before any procedure was applied. 
During  an  incision  biopsy,  destruction  of  the 
anterolateral  wall  of  the  left-maxillary  sinus 
was  observed.  The  tumor  under  the  periost 
was in accord with the maxillary sinus mucosa, 
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but  continued  with  a  soft,  fragile,  hyperplasic, 
reddish-purple lesion underneath. The lesion had 
tendency to bleeding easily and the hemorrhage 
occurred during biopsy was able to be controlled 
with  haemostatic  agents.  Histopathological 
examination revealed it to be a well differentiated 
(Grade  I)  fibrosarcoma  (Figure  6a,  b,  c,  d).  HE-
stained histopathological sections of fibrosarcoma 
showed spindle-cells crossing each other under 
the  pseudo-stratified  ciliary’s  epithelium  at  the 
surface (Figure 6a (40xHE)) and a mitosis (Figure 
6b, arrow, (400xHE)). Vimentin was seen diffuse 
Figure  1.  Histopathological  sections  of  gemistocytic 
astrocytoma. The sections are characterized with predominance 
of  gemistocytes,  which  are  neoplastic  cells  (1a  (100xHE),  1b 
(200xHE)). Voluminous, eosinophilic cytoplasm, eccentric nuclei, 
plump  cell  process  and  marked  cytoplasmic  accumulation 
of glial fibrillary acidic protein (gemistocytes) are seen in the 
histopathological sections.
Figure  3.  Relatively  localized  decrease  in  left-maxillary 
vestibular depth from canine to the second premolar region.
Figure 4. Orthopantomography shows resorption at the internal 
surface of the left-maxillary sinus.
Figure 2. CT-images belong to brain and maxillary sinus. Ct-
images  taken  before  any  procedure  applied  illustrating  two 
separate  tumors  in  the  brain  (2a)  and  left-maxillary  sinus 
(2b).  Note  the  enhancing  heterogeneous  tumor  at  the  left-
temporoparietal lobe shifting the midline to the right (2a); and 
invasion of the tumor (T4) in the left-maxillary sinus into the 
adjacent tissues (2b). 
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positive in tumor tissue (Figure 6c (100xVimentin)) 
whereas  SMA  was  seen  negative  in  tumor 
tissue and positive in the vessel wall (Figure 6d 
(100xSMA)).
According  to  treatment  plan,  having  partial 
maxillectomy  was  performed  (Figure  7a,  b,  c), 
the  floor  of  the  orbit  was  reconstructed  with 
prolene  mesh  (Figure  7d)  and  split-skin  grafts 
were applied to the excision site (Figure 7e). An 
immediate  obturator  with  1  cm  extension  into 
the  excision  side  was  stabilized  with  adams 
retention  clasp  to  support  the  defect  area  and 
splint-skin  graft  on  the  day  of  surgery  (Figure 
7f,  g,  h).  Greater  retention  and  stability  was 
achieved  with  peridental  ligatures.  The  patient 
demonstrated  good  postoperative  progress 
and  10  days  after  the  surgery  the  immediate 
prosthesis  was  subsequently  replaced  by  an 
interim obturator which was then replaced with a 
definitive  prosthesis  after  three-months  (Figure 
7i) for palate reconstruction. All obturators were 
fabricated  with  heat-polymerizing  acrylic  resin 
(Meliodent,  Heraeus  Kulzer,  Germany).  Patient 
was  satisfied  with  appearance  as  well  as  the 
function. 
Histopathological  examination  of  the  excised 
mass  confirmed  the  previous  diagnosis  of 
fibrosarcoma.  There  was  no  recurrence  or 
Figure 5. Maxillary occlusal radiograph illustrates an enlarged 
left maxillary sinus with poorly defined margins.
Figure 7 . Clinical and surgical photographs of the patient. An incision line for partial maxillectomy (7a); exposed anterior wall of the 
maxillary sinus with fibrosarcoma (7b); excised tumor (7c); reconstruction of the floor of the orbit with prolen mesh (7d); application 
of full thickness skin graft (7e); intermit splint (7f) and its replacement for temporary reconstruction (7g); repositioning of the flap 
(7h); final reconstruction of the maxilla with an obturator (7i); leukocytoclastic vasculitis occurred on the face (7j) and leg (7k); skin 
graft lesions occurred (7l).
Figure  6.  The  histopathological  sections  of  fibrosarcoma.   
Spindle-cells  under  the  pseudo-stratified  ciliary’s  epithelium 
at the surface, spindle-cells crossing each other (6a (40xHE)) 
and a mitosis (6b (400xHE)) are seen. Vimentin is diffuse positive 
in tumor tissue (6c (100xVimentin)), SMA is negative in tumor 
tissue and positive in the vessel wall (6d (100xSMA)).
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distant metastases of the brain tumor at the time 
of  maxillary  sinus  fibrosarcoma  operation.  An 
immediate postoperative course was uneventful. 
Patient received adjuvant radiotherapy with a total 
of 5000cGy in 5-weeks (200 cGy / day; 5 days / a 
week)  with  Cobalt-60  Penatherapy  (Picker  ATC 
C-9)  three-months  after  the  operation.  Acute 
reactions to radiotherapy were mild and relatively 
self-limiting. Among these reactions, generalized 
skin lesions distributed to whole body at the third-
week of radiotherapy was prominent. However the 
lesions had been already subsided with residual 
pigmentation  spontaneously,  since  the  patient 
presented  to  our  clinic  two-weeks  after  the 
occurrence of the lesions (Figure 7j, k). The skin 
graft also underwent changes in appearance and 
had distressing smell during this period (Figure 
7l).  Therefore,  it  was  revised  under  general 
anesthesia  and  an  incision  biopsy  was  obtained 
for  the  possibility  of  recurrence.  The  specimen 
was  interpreted  as  inflammatory  granulation 
tissue. There was clear response to oral etodolac 
(400  mg;  3x1)  with  significant  resolution  of  the 
lesion without any recurrence. Biopsies were also 
performed for the skin lesions and subsequently 
interpreted as leukocytoclastic vasculitis (Figure 
8),  which  was  characterized  with  perivascular 
infiltration of granulocytes (PMN), karrhyorhexis 
of  their  nuclei  (leukocytoclasia)  and  damage  of 
the vessel wall, coupled with compromise of the 
lumen and extravasations of erythrocytes within 
the dermis (100xHE).
Patient had no local recurrences at the primary 
sites;  however,  had  distant  metastases  to  lung, 
spinal and femoral bones two-years after the first 
operation  as  detected  with  scintigraphy.  Patient 
rejected further chemotherapy and was followed 
on  regular  calls  for  another  6-month  until  died 
following  increased  intracranial  edema  induced 
paralysis.
dISCuSSIoN
We reported a case, who developed synchronous 
maxillary  sinus  fibrosarcoma  and  gemistocytic 
astrocytoma of brain. Synchronous malignancies 
are  rare  occurrences  and,  in  general,  their 
pathogenesis is unknown. In general, the possible 
mechanisms for synchronous malignancies may 
range from heredity, age, a genetic link between 
the cancers, immunological-, and environmental-
state to simply coincidence. Up to 44% of paranasal 
sinus malignancies are attributed to occupational 
exposures, including nickel, chromium, isopropyl 
oils,  volatile  hydrocarbons,  and  organic  fibers 
that  are  found  in  the  wood,  shoe,  and  textile 
industries.12  In  addition,  human  papillomavirus 
can  be  a  cofactor.12  Specific  associations  found 
include  squamous  cell  carcinoma  in  nickel 
workers and adenocarcinoma in workers exposed 
to hardwood dust and leather tanning.12 Since the 
presented case is the first, it is difficult to identify 
etiology of both tumors. However, the presence 
of  cancer  in  his  family  and  his  occupation  may 
suggest either genetic tendency or occupational 
exposure as causative factors. No other etiologies 
or risk factors were identified.
Early diagnosis seems to be the most important 
factor  in  the  management  of  paranasal  sinus 
malignancies,  since  the  primary  cause  of  death 
is  failure  to  control  local  disease.  However,  in 
accordance  with  our  case  (T4  stage),  malignant 
tumors of the paranasal sinuses are often found 
to be greatly advanced at the primary site by the 
time diagnosis is established (~75% patients).12 In 
that sense, the relative lack of specific symptoms 
indicating that malignancy is present or lack of 
awareness and cautious on routine radiographic 
findings  seems  to  be  reasons  behind  such 
misinterpretation  and  delay  in  diagnosis.  Key 
symptoms of malignancy are cranial neuropathies 
and  proptosis.  However,  these  are  uncommon 
at  initial  presentation  and  suggest  advanced 
disease.12 Sign and symptoms of maxillary sinus 
carcinoma  could  be  classified  as  nasal,  ocular, 
facial,  auditory  and  oral.12  Nasal  findings  occur 
approximately  50%  of  patients  and  consist  of 
obstruction,  discharge,  stuffiness,  congestion, 
epistaxis,  and  extension  into  the  nasal  cavity. 
Ocular findings are seen in up to 25% of patients 
and arise from upward extension into the orbit, 
where unilateral tearing, diplopia, fullness of lids, 
pain,  and  exophthalmos  are  seen.  Facial  signs 
comprise  infraorbital  nerve  hypestesia,  cheek 
swelling,  pain,  and  facial  asymmetry.  Audiotory 
complaints  consist  of  hearing  loss  secondary 
to  serous  otitis  media  due  to  nasopharyngeal 
extension.  Finally,  oral  presentations  arise  in 
25-35% of patients and include pain involving the 
maxillary dentition, trismus, palatal and alveolar 
ridge  fullness,  and  frank  erosion  into  the  oral 
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cavity. Multiple unilaterally missing left maxillary 
teeth in the presented case indicates to unrealized 
maxillary  sinus  fibrosarcoma  development,  and 
related  pain  as  a  causative  factor  for  previous 
extractions.  It  should  also  be  emphasized 
that  although  advanced  imaging  techniques 
often  provide  important  additional  diagnostic 
information  which  can  help  guide  patient 
management,  conventional  radiographs  (e.g. 
OPG, maxillary occlusal radiograph or periapical 
radiographs) may also be valuable for the initial 
diagnosis of a lesion in the maxillary sinus as seen 
in the presented case. Since the success in the 
management and prognosis in cancer patients is 
highly associated with early diagnosis, suspicion 
leading  to  more  detailed  investigations  should 
be  performed  when  patients  do  not  respond  to 
routine dental therapy.
The survival of patients with fibrosarcoma is 
intermediate (60-70%) in head and neck region,2 
poor  (30-50%  for  5-year)  in  maxillary  sinus,13 
and worst in gemistocytic astrocytoma (16% for 
5-years;  0%  for  10-years).7  The  overall  survival 
of our patient was 2.5-years. The possible factors 
influenced the survival negatively were male sex, 
increasing  age,  higher  TNM  staging,  site  of  the 
tumor (worse in the maxilla) for fibrosarcoma;11 
and  age,  tumor  grade  and  histological  type 
(Grade II – poorly differentiated) for gemistocytic 
astrocytoma.5,7 
It was difficult to apply a standard treatment 
protocol for the presented case due to absence 
of  the  similar  presentation  in  the  literature. 
Therefore,  understanding  of  the  clinical 
behaviors of the tumors in response to therapy 
was also vague. The best treatment protocol for 
such  patients  awaits  further  documentations 
and  investigations.  However,  in  relevance  with 
maxillofacial  surgery,  wide  surgical  resection 
with  clear  margins  is  important  for  a  favorable 
survival, since fibrosarcoma is more of a locally 
destructive  problem  (recurrence  rate:  ~30-
66.7%)14  than  a  metastatic  problem  (distant 
metastases  rate:  ~20%).14  Furthermore,  it  is 
known that postoperative radiotherapy is capable 
to augment surgical 5-year cure rate by 10-15%.14 
Therefore the combined modality of surgery and 
adjuvant radiotherapy, which is widely accepted to 
be the most effective combination,15,16 was used for 
the presented case. However, distant metastases 
and the survival period of this case may suggest 
that  application  of  chemotherapy,  which  is 
interventional at present, as a third modality may 
have  additional  value  for  the  management  and 
longer  survival  of  such  cases.  Our  assumption 
seems to be supported with a study reported the 
beneficial effect of chemotherapy in combination 
with surgery or radiotherapy.11   
Development  of  leukocytoclastic  vasculitis, 
which  is  an  autoimmune  disease,  during  the 
course  of  radiotherapy,  was  another  unusual 
observation  in  the  presented  case.  Although,  it 
could  be  discussed  whether  the  precipitating 
factor  for  the  leukocytoclastic  vasculitis  was 
radiotherapy  or  malignancies,17  it  is  known  that 
leukocytoclastic  vasculitis  may  also  develop 
independent from any cancer.18 To our knowledge, 
the  induction  of  leukocytoclastic  vasculitis  has 
not been reported in the context of radiotherapy, 
so  far.  Whether  autoimmune  phenomena  occur 
after irradiation therapy is obscure and requires 
further  investigations  to  explore.  Whatsoever, 
such unusual presentation and clinical hallmarks 
of leukocytoclastic vasculitis lead we to emphasize 
that  cancer  patients  will  receive  radiotherapy 
should be monitored for the potential development 
of leukocytoclastic vasculitis.
This report constitutes data in terms of clinical 
course,  prognosis,  treatment  modality  and 
survival of such synchronous malignant tumors, 
and open discussion on likelihood radiotherapy-
induced leukocytoclastic vasculitis.
Figure  8.  Histopathological  section  of  leukocytoclastic 
vasculitis.  Section  is  characterized  with  perivascular 
infiltration of granulocytes (PMN), karrhyorhexis of their nuclei 
(leukocytoclasia) and damage of the vessel wall, coupled with 
compromise of the lumen and extravasations of erythrocytes 
within the dermis (100xHE).
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